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SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 308 (FGE.308): 
Glucose Pentaacetate and Sucrose Octaacetate1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
European Food Safety Authority (EFSA), Parma, Italy 
 
SUMMARY  
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to evaluate two flavouring substances in the 
Flavouring Group Evaluation 308, using the Procedure as referred to in the Commission Regulation 
(EC) No 1565/2000. These two flavouring substances belong to chemical group 30 Annex I of the 
Commission Regulation (EC) No 1565/2000. 
The candidate substances are glucose pentaacetate [FL-no: 09.258] and sucrose octaacetate [FL-
16.081]. 
The candidate substances [FL-no: 09.258 and 16.081] possess four and nine chiral centres, 
respectively. The stereoisomeric compositions have been specified for both substances..  
The candidate substances belong to structural class II. 
None of the substances have been reported to occur naturally in foods. 
                                                     
 
1  On request from the Commission, Question No EFSA-Q-2010-01504 and EFSA-Q-2010-01505, adopted on 4 February 
2011. 
2  Panel members Arturo Anadon, Mona-Lise Binderup, Wilfried Bursch, Laurence Castle, Riccardo Crebelli, Karl-Heinz 
Engel, Roland Franz, Nathalie Gontard, Thomas Haertle, Trine Husøy, Klaus-Dieter Jany, Catherine Leclercq, Jean 
Claude Lhuguenot, Wim Mennes, Maria Rosaria Milana, Karla Pfaff, Kettil Svensson, Fidel Toldra, Rosemary Waring, 
Detlef Wölfle. Correspondence: cef-unit@efsa.europa.eu  
3  Acknowledgement: The Panel wishes to thank the members of the Working Groups on Flavourings for the preparation of 
this Opinion: Ulla Beckman Sundh, Vibe Beltoft, Wilfried Bursch, Angelo Carere, Karl-Heinz Engel, Henrik Frandsen, 
Rainer Gürtler, Frances Hill, Trine Husøy, John Christian Larsen, Pia Lund, Wim Mennes, Gerard Mulder, Karin Nørby, 
Gerard Pascal, Iona Pratt, Gerrit Speijers, Harriet Wallin and EFSA’s staff member Kim Rygaard Nielsen for the 
preparatory work on this scientific Opinion. 
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In its evaluation, the Panel as a default used the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
Panel examined the information provided by the European Flavouring Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach.  
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. 
The estimated daily per capita intake of the two candidate substances are 0.061 microgram [FL-no: 
09.258] and 210 microgram [FL-no: 16.081]. These are below the threshold of concern for structural 
class II. 
It is concluded that the genotoxicity data available do not preclude the evaluation of these substances 
through the Procedure.  
The metabolism data available were sufficient to conclude that the candidate substances are rapidly 
absorbed, metabolised to innocuous products and excreted through normal biological mechanisms.  
A 90-day study is available on the candidate substance glucose pentaacetate [FL-no: 09.258] which is 
considered to be supporting for both substances in subgroup two. 
The estimated intake for each of the two candidate substances [FL-no: 09.258 and 16.081] in structural 
class II, based on the mTAMDI, is 230000 and 2700 microgram/person/day, respectively, which is 
above the threshold of concern of 540 microgram/person/day. Thus, for the candidate substances [FL-
no: 09.258 and 16.081] further information is required. This would include more reliable intake data 
and then, if required, additional toxicological data. 
In order to determine whether the conclusion for the candidate substances which have been evaluated 
using the Procedure can be applied to the materials of commerce, it is necessary to consider the 
available specifications. Adequate specifications including complete purity criteria and identity for the 
materials of commerce have been provided for the two flavouring substances evaluated through the 
Procedure. 
Thus, the two substances glucose pentaacetate [FL-no: 09.258] and sucrose octaacetate [FL-no: 
16.081] would present no safety concern at the levels of intake estimated on the basis of the MSDI 
approach.   
 
© European Food Safety Authority, 2011 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
After the completion of the evaluation programme the Union List of flavouring substances for use in 
or on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register prior to their authorisation and inclusion in a Union List according to 
Commission Regulation (EC) No 1565/2000 (EC, 2000a). In addition, the Commission requested 
EFSA to evaluate newly notified flavouring substances, where possible, before finalising the 
evaluation programme. 
In addition, in letter of 17 May 2010 the Commission requested EFSA to carry out a risk assessment 
on glucose pentaacetate [FL-no: 09.258] and sucrose octaacetate [FL-16.081] in accordance with 
Commission Regulation (EC) No 1565/2000: 
“The European Commission requests the European Food Safety Authority to carry out a safety 
assessment on glucose pentaacetate [FL-no: 09.258] and sucrose octaacetate [FL-16.081], in 
accordance with Commission Regulation (EC) No 1565/2000 by end 2010”.   
The deadline of the Terms of Reference was negotiated to 30 May 2011. 
ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 308 
1.1. Description 
The present revision of Flavouring Group Evaluation 308 (FGE.308), using the Procedure as referred 
to in the Commission Regulation (EC) No 1565/2000 (the Procedure – shown in schematic form in 
Annex I of this FGE), deals with two flavouring substances (candidate substances) from chemical 
group 30 of Annex I of Commission Regulation (EC) No 1565/2000 (EC, 2000a).  
The candidate substances under consideration in the present evaluation, with their chemical Register 
names, FLAVIS- (FL-), Chemical Abstract Service- (CAS-), Council of Europe- (CoE-) and Flavor 
and Extract Manufacturers Association- (FEMA-) numbers, and structures are listed in Table 1. 
No supporting substances have been identified for this group. 
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The outcome of the safety evaluation is summarised in Table 2a. 
1.2. Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. Their 
flavour may be different, they may have different chemical properties resulting in possible variability 
in their absorption, distribution, metabolism, elimination and toxicity. Thus, information must be 
provided on the configuration of the flavouring substance, i.e. whether it is one of the 
geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of 
purity will be considered in order to determine whether the safety evaluation carried out for candidate 
substances for which stereoisomers may exist can be applied to the material of commerce. Flavouring 
substances with different configurations should have individual chemical names and codes (CAS 
number, FLAVIS number etc.). 
The two candidate substances [FL-no: 09.258 and 16.081] possess four and nine chiral centres, 
respectively. The stereoisomeric compositions have been specified for both substances (Flavour 
Industry, 2010e) (see Table 1).  
1.3. Natural Occurrence in Food 
The two candidate substances are not reported to occur naturally in any food items (TNO, 2010). 
2. Specifications 
Purity criteria for the substances have been provided by the Flavour Industry (Flavour Industry, 
2010e) (Table 1). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000a), this information is adequate for both candidate substances (see Section 1.2 and Table 1). 
3. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production 
figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU 
population are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties 
in the underreporting correction factor and to uncertainties in the percentage of consumers, the 
reliability of intake estimates on the basis of the MSDI approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
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as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004a). 
3.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). These 
data are derived from surveys on annual production volumes in Europe. These surveys were conducted 
in 1995 by the International Organization of the Flavour Industry, in which flavour manufacturers 
reported the total amount of each flavouring substance incorporated into food sold in the EU during 
the previous year (IOFI, 1995). The intake approach does not consider the possible natural occurrence 
in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population4 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
The total annual volume of production of the two candidate substances in the present Flavouring 
Group Evaluation (FGE.308) from use as flavouring substances in Europe has been reported to be 
approximately 1000 (Flavour Industry, 2010e).  
On the basis of the annual volumes of production reported for the two candidate substances, the daily 
per capita intakes for each of these flavourings have been estimated. The estimated daily per capita 
intake of glucose pentaacetate [FL-no: 09.258] is 0.061 microgram and that of sucrose octaacetate 
[FL-no: 16.081] is 210 microgram (Table 2). 
3.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
For the candidate substances information on food categories and normal and maximum use levels5,6 
were submitted by the Flavour Industry (Flavour Industry, 2010e).  
The two candidate substances are used in flavoured food products divided into the food categories, 
outlined in Annex III of the Commission Regulation (EC) No 1565/2000 (EC, 2000a), as shown in 
                                                     
 
4 EU figure 375 millions. This figure relates to EU population at the time for which production data are 
available, and is consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No 
production data are available for the enlarged EU. 
5 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile of reported 
usages (EFFA, 2002i). 
6 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from figures derived 
from 12 model flavouring substances (EFFA, 2004e). 
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Table 3.1. For the present calculation of mTAMDI, the reported normal use levels were used. In the 
case where different use levels were reported for different food categories the highest reported normal 
use level was used. 
Table 3.1 Use of Two of Three Candidate Substances 
Food 
category 
Description Flavourings used 
01.0 Dairy products, excluding products of category 2 None 
02.0 Fats and oils, and fat emulsions (type water-in-oil) Only [FL-no: 16.081] 
03.0 Edible ices, including sherbet and sorbet Only [FL-no: 16.081] 
04.1 Processed fruits None 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and 
legumes), and nuts & seeds 
None 
05.0 Confectionery Only [FL-no: 16.081] 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses 
& legumes, excluding bakery 
None 
07.0 Bakery wares Only [FL-no: 16.081] 
08.0 Meat and meat products, including poultry and game Only [FL-no: 09.258] 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  None 
10.0 Eggs and egg products None 
11.0 Sweeteners, including honey None 
12.0 Salts, spices, soups, sauces, salads, protein products etc. None 
13.0 Foodstuffs intended for particular nutritional uses None 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products Both 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts Only [FL-no: 16.081] 
15.0 Ready-to-eat savouries None 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not 
be placed in categories 1 – 15 
None 
 
According to the Flavour Industry the normal use levels for the two candidate substances are in the 
range of 5.18 - 5.46 mg/kg food for [FL-no: 16.081] and 100 - 1500 mg/kg food for [FL-no: 09.258], 
and the maximum use levels are in the range of 8.72-9.92 mg/kg food for [FL-no: 16.081] and 100 - 
1500 mg/kg food for [FL-no: 09.258] (Flavour Industry, 2010e) (see Table II.1.2, Annex II). 
The mTAMDI value is respectively 230000 and 2700 microgram/person/day for the candidate 
substances [FL-no: 09.258] and [FL-no: 16.081] from structural class II (see Section 5).  
For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
4. Absorption, Distribution, Metabolism and Elimination 
For the two candidate substances, data on the absorption and metabolism of one of the candidate 
substances glucose pentaacetate [FL-no: 09.258] have been submitted (Domingues et al., 1960). 
Using 14C labels in both the glucose and acetate moieties, it was found that β-D-glucose pentaacetate 
is rapidly absorbed, metabolised and excreted primarily as expired carbon dioxide.  
Partial hydrolysis of β-D-glucose pentaacetate occurs with the more highly acetylated molecules being 
excreted in the urine more quickly than the lower acetylated molecules. 
It is anticipated that sucrose octaacetate would be metabolised in a similar way as glucose 
pentaacetate.  
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It can be anticipated that the candidate substances are metabolised to innocuous products and rapidly 
excreted. 
For more detailed information, see Annex III. 
5. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the safety evaluation of the candidate substances from chemical group 30 the Procedure as 
outlined in Annex I was applied, based on the MSDI approach. The stepwise evaluations of the 
substances are summarised in Table 2. 
Step 1 
The two candidate substances glucose pentaacetate [FL-no: 09.258] and sucrose octaacetate [FL-
16.081] are classified according to the decision tree approach by Cramer et al. (Cramer et al., 1978) 
into structural class II. 
Step 2 
Step 2 requires consideration of the metabolism of the candidate substances. It can be anticipated that 
glucose pentaacetate [FL-no: 09.258] and sucrose octaactetate [FL-16.081] are metabolised to 
innocuous products. Accordingly, the evaluation of these candidate substances proceeds via the A-side 
of the Procedure scheme.  
Step A3 
The two candidate substances glucose pentaacetate [FL-no: 09.258] and sucrose octaactetate [FL-
16.081] have estimated European daily per capita intakes of 0.061 and 210 microgram, respectively 
(Table 2). These intakes are below the threshold of concern of 540 microgram/person/day for 
structural class II.  
Based on results of the safety evaluation sequence of the Procedure, these two candidate substances, 
proceeding via the A-side of the Procedure scheme, do not pose a safety concern when used as 
flavouring substances at the estimated levels of intake, based on the MSDI approach. 
6. Comparison of the Intake Estimations Based on the MSDI Approach and the mTAMDI 
Approach 
The estimated intake for each of the two candidate substances [FL-no: 09.258 and 16.081] in structural 
class II, based on the mTAMDI, is 230000 and 2700 microgram/person/day, respectively, which is 
above the threshold of concern of 540 microgram/person/day.  
Thus, for the candidate substances [FL-no: 09.258 and 16.081] further information is required. This 
would include more reliable intake data and then, if required, additional toxicological data. 
For comparison of the MSDI and mTAMDI values, see Table 6.1. 
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Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
09.258 Glucose pentaacetate 0.061 230000 Class II 540 
16.081 Sucrose octaacetate 210 2700 Class II 540 
7. Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and supporting substances, it can be anticipated that 
many of the flavourings are metabolised through the same metabolic pathways and that the 
metabolites may affect the same target organs. Further, in case of combined exposure to structurally 
related flavourings, the pathways could be overloaded. Therefore, combined intake should be 
considered. As flavourings not included in this FGE may also be metabolised through the same 
pathways, the combined intake estimates presented here are only preliminary. Currently, the combined 
intake estimates are only based on MSDI exposure estimates, although it is recognised that this may 
lead to underestimation of exposure. After completion of all FGEs, this issue should be readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. 
On the basis of the reported annual production volumes in Europe (EFFA, 2008c; Flavour Industry, 
2010e), the combined estimated daily per capita intake as flavourings of the two candidate substances 
belonging to structural class II is approximately 210 microgram. This value does not exceed the 
threshold of concern for structural class II of 540 microgram/person/day. 
8. Toxicity 
8.1. Acute Toxicity 
Data are available for one of the candidate substances, sucrose octaactetate [FL-no: 16.081]. The oral 
LD50 value in mice is 1600 mg/kg body weight (bw). 
The acute toxicity data are summarised in Annex IV, Table IV.1. 
8.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
Subacute and subchronic toxicity data are available for one of the candidate substances (glucose 
pentaacetate [FL-no: 09.258]). 
A 90-days study has been carried out using dietary levels of β-D glucose pentaacetate of 0 %, 1 %, 5 
% and 10 % in the diet, equivalent to 1, 5 and 10 g/kg body weight (bw)/day. Comparison with control 
animals revealed no differences between the groups, except a significant increase in lung weights was 
observed in all male test groups, although this did not appear to be dose related. Subsequent to this 
study, a group of 4 animals were maintained for 2 years from the high dose group with no adverse 
effects observed, although this was not carried out in accordance with guidelines for a 2 year 
carcinogenicity study (Zeitlin et al., 1960). 
A further search in open literature did not provide any further relevant information.  
Repeated dose toxicity data are summarised in Annex IV, Table IV.2. 
Flavouring Group Evaluation 308
 
 
10 EFSA Journal 2011; 9(3):2014 
8.3. Developmental / Reproductive Toxicity Studies 
No data on developmental toxicity and reproductive toxicity have been identified for any of the 
candidate substances. 
8.4. Genotoxicity Studies 
In vitro data are only available for one candidate substance, sucrose octaactetate [FL-no: 16.081] with 
an Ames test, an UDS assay and a Mouse lymphoma forward mutation assay all giving negative 
results (Heck et al., 1989). Overall, the limited data available do not preclude their evaluation through 
the Procedure. 
A further search in open literature did not provide any further relevant information.  
Genotoxicity data are summarised in Annex IV, Table IV.4. 
9. Conclusions 
The two candidate substances are compounds containing acetate moieties from chemical group 30. 
The two candidate substances glucose pentaacetate [FL-no: 09.258] and sucrose octaacetate [FL-
16.081] possess four and nine chiral centres, respectively. The stereoisomeric compositions have been 
specified for both substances. The two candidate substances belong to structural class II [FL-no: 
09.258 and 16.081]. 
None of the substances have been reported to occur naturally in foods. 
The estimated daily per capita intake of glucose pentaacetate [FL-no: 09.258] is 0.061 microgram and 
that of sucrose octaacetate [FL-no: 16.081] is 210 microgram. These are below the threshold of 
concern for structural class II. 
It is concluded that the genotoxicity data available do not preclude the evaluation of these substances 
through the Procedure.  
The metabolism data available were sufficient to conclude that the candidate substances are rapidly 
absorbed, metabolised to innocuous products and excreted through normal biological mechanisms.  
A 90-day study is available on the candidate substance glucose pentaacetate [FL-no: 09.258] which is 
considered to be supporting for both substances. 
The estimated intake for each of the two candidate substances [FL-no: 09.258 and 16.081] in structural 
class II, based on the mTAMDI, is 230000 and 2700 microgram/person/day, respectively, which is 
above the threshold of concern of 540 microgram/person/day. Thus, for the candidate substances 
further information is required. This would include more reliable intake data and then, if required, 
additional toxicological data. 
In order to determine whether the conclusion for the candidate substances which have been evaluated 
using the Procedure can be applied to the materials of commerce, it is necessary to consider the 
available specifications. Adequate specifications including complete purity criteria and identity for the 
materials of commerce have been provided for the two flavouring substances evaluated through the 
Procedure. 
Thus, the two substances glucose pentaacetate [FL-no: 09.258] and sucrose octaacetate [FL-no: 
16.081] would present no safety concern at the levels of intake estimated on the basis of the MSDI 
approach. 
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 308 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 308 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
09.258 
 
Glucose pentaacetate 
O
O
O
O
O
O
OO
OO
O
RSRR
2524 
 
3891-59-6 
Solid 
C16H22O11 
390.34 
Practically insoluble 
Sparingly soluble 
 
110-115 
NMR MS 
95 % 
n.a. 
n.a. 
 
The CASrn referes to the D-Glucose 
pentaacetate. Industry informs that 
the 95 % assay minimum covers the 
complete acetylated D-glucose (D-
glucose pentaacetate).  
16.081 
 
Sucrose octaacetate 
O
O
O
O
O
OO
O
O
O
O
O O
O
O
O
O
O
O
R
R
RS
R S
S
R
R
3038 
11819 
126-14-7 
Solid 
C28H38O19 
678.60 
Slightly soluble 
Freely soluble 
260 
82-89 
NMR 
95 % 
n.a. 
n.a. 
 
Industry informs that the 95 % assay 
minimum covers the complete 
acetylated alpha-D-glucopyranoside. 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
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TABLE 2: SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
Table 2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the material 
of commerce [6), 7), or 8)] 
Evaluation remarks 
09.258 
 
Glucose pentaacetate 
O
O
O
O
O
O
OO
OO
O
RSRR
0.061 
 
Class II 
A3: Intake below threshold 
4) 6)  
16.081 
 
Sucrose octaacetate 
O
O
O
O
O
OO
O
O
O
O
O O
O
O
O
O
O
O
R
R
RS
R S
S
R
R
210 
 
Class II 
A3: Intake below threshold 
4) 6)  
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day , Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 microgram/person/day, 
respectively, are derived from a large database containing data on subchronic and chronic animal studies 
(JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
• can the flavourings be predicted to be metabolised to innocuous products7 (Step 2)?  
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
• are the flavourings or their metabolites endogenous8 (Step A4)?  
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
 
                                                     
 
7 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the 
estimated intakes of the flavouring agent” (JECFA, 1997a). 
 
8 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997a). 
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety 
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is  high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern
Is the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4.
 Yes No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
Flavouring Group Evaluation 308
 
 
15 EFSA Journal 2011; 9(3):2014 
ANNEX II: USE LEVELS / MTAMDI 
II.1 Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a) 
Food category Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry for the two candidate substances in the 
present flavouring group (Table II.1.2). 
Table II.1.2.Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.308 (Flavour 
Industry, 2010e). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
09.258 - 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
1500 
1500 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
100 
100 
- 
- 
- 
- 
- 
- 
16.081 - 
- 
5,46 
8,77 
5,4 
8,77 
- 
- 
- 
- 
5,4 
8,72 
- 
- 
5,46 
8,77 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
5,18 
9,92 
5,18 
9,92 
- 
- 
- 
- 
II.2 mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
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Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
• Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
• Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
• Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
• Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
• Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
• Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) 
• Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be Food   
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Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
placed in categories 01.0 - 15.0 
 
The mTAMDI values (see Table II.2.3) are presented for the two flavouring substances in the present 
flavouring group, for which Industry has provided use and use levels (Flavour Industry, 2010e). The 
mTAMDI values are only given for the highest reported normal use levels. 
TableII.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(μg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
09.258 Glucose pentaacetate 230000 Class II 540 
16.081 Sucrose octaacetate 2700 Class II 540 
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ANNEX III: METABOLISM 
III.1. Introduction 
The present FGE consists of two candidate substances glucose pentaacetate [FL-no: 09.258] and sucrose 
octaacetate [FL-no: 16.081]. 
III.2. Absorption, Distribution and Elimination 
For the candidate substances data are available on glucose pentaacetate [FL-no: 09.258]. Using 14C labels in 
both the glucose and acetate moieties, it was found that β-D-glucose pentaacetate is rapidly absorbed, 
metabolised and excreted primarily as expired carbon dioxide (Domingues et al., 1960).  
Absorption of glucose pentaacetate was almost complete within 4 hours. Absorption measured using glucose 
and acetate concentrations showed that the molecule is being partially hydrolysed in the GI tract and then the 
acetate moiety is rapidly absorbed.  
Partial hydrolysis of β-D-glucose pentaacetate occurs with the more highly acetylated molecules being 
excreted in the urine more quickly than the lower acetylated molecules (Domingues et al., 1960). After 48 
hours only 2 % of the radioactivity was measured in the faeces of the animals.  
Of the acetate labelled molecule, 80 % of the radioactive label was excreted as expired carbon dioxide up to 
48 hours after dosing and peaking at around 4 hours after dosing, whereas for the glucose labelled molecule, 
these figures were 65 % and one hour. These differences suggest that the molecule is only partially 
hydrolysed in the GI tract. Urinalysis of the rats fed the glucose labelled molecule showed that 11 % of the 
radiolabel was excreted in the urine compared to 4 % for the acetate labelled molecule. 
It is anticipated that sucrose octaacetate would be absorbed, distributed and eliminated in a similar way to 
glucose pentaacetate.  
A study was carried out using two similar substances, sucrose acetate isobutyrate and sucrose octaisobutyrate 
in rats, dogs, monkeys and humans (Reynolds, 1998). In humans, the majority (41-66 %) of the orally 
administered dose of 14C sucrose acetate isobutyrate was eliminated as carbon dioxide within 11 days of 
dosing with the maximal rate of elimination occurring between 9 and 16 hours after dosing. Urinary 
elimination was rapid and accounted for 14-21 % of the dose and around 10 % of the dose was recovered in 
the faeces. The authors of this paper conclude that sucrose acetate isobutyrate is extensively metabolised in 
the GI tract probably to sucrose and partially acetylated sucrose and eliminated rapidly. 
III.3. Metabolism 
There are little data on the metabolism of the candidate substances. 
Partial hydrolysis of β-D-glucose pentaacetate to acetate and various acetylated glucose derivatives occurs in 
the GI tract. Using chromatography of the urine, it was determined that as time progressed, the concentration 
of higher acetylated glucose derivatives decreased and the concentration of lower acetylated derivatives 
increased, suggesting that over time, continual deacetylation occurs (Domingues et al., 1960). 
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It is anticipated that sucrose octaacetate would be metabolised in a similar way as glucose pentaacetate.  
Acetate is a normal metabolite in the body and is converted to acetyl CoA and enters the citric acid cycle 
(Stryer, 1988). 
III.4. Summary and Conclusions 
It can be anticipated that the two candidate substances are metabolised to innocuous products and rapidly 
excreted primarily in the expired air with lower concentrations in the urine and lower still in the faeces. 
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ANNEX IV: TOXICITY 
Oral acute toxicity data are available for one candidate substance of the present Flavouring Group Evaluation from chemical group 30. 
TABLE IV.1: ACUTE TOXICITY 
Chemical Name [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  Comments 
Sucrose octaacetate [16.081] Mice NR NR 1600 (Schafer & Bowles, 1985)  
NR: Not reported 
 
 
 
 
Subacute / Subchronic / Chronic / Carcinogenic toxicity data are available for one candidate substance of the present Flavouring Group Evaluation from 
chemical group 30. 
TABLE IV.2: SUBACUTE / SUBCHRONIC / CHRONIC / CARCINOGENICITY STUDIES 
Chemical Name [FL-no] Species; Sex 
No./Group 
Route Dose levels Duration NOAEL 
(mg/kg bw/day) 
Reference Comments 
Glucose pentaacetate [09.258] Rats; M, F 
10 
Oral 0, 1, 5, 10 g/kg 
bw/day 
90 days 10 (Zeitlin et al., 1960) Subsequent to this study, a group of 4 animals were maintained 
for 2 years from the high dose group with no adverse effects 
observed, although this was not carried out in accordance with 
guidelines for a 2 year carcinogenicity study. 
 
 
DEVELOPMENTAL AND REPRODUCTIVE TOXICITY STUDIES 
No developmental or reproductive toxicity data are available for the candidate substances of the present Flavouring Group Evaluation from chemical group 
30. 
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In vitro mutagenicity/genotoxicity data are available for one candidate substance of the present Flavouring Group Evaluation from chemical group 30. 
TABLE IV.4: GENOTOXICITY (IN VITRO) 
Chemical Name [FL-no] Test System Test Object Concentration 
 
Result Reference Comments 
Sucrose octaactetate [16.081] Ames assay S. typhimurium TA1535, 
TA1537, TA1538, TA98, 
TA100 
Up to 10000 microg/plate Negative1 (Heck et al., 1989) Published non-GLP study. No information concerning a possible 
cytotoxic effect nor on the number of concentrations tested. The 
test guidelines do not require more than 5 mg/plate. Due to the 
lack of some important details of study design and results the 
validity of the study cannot be evaluated.  
 
 Unscheduled DNA 
synthesis 
Rat primary hepatocytes 509 microg/ml Negative (Heck et al., 1989) Some important details of method and results are not reported. 
Thus, the validity of this study cannot be evaluated. 
 
 Mouse lymphoma 
assay 
L5178Y tk +/-  
mouse lymphoma cells 
2000 microg/ml Negative1 (Heck et al., 1989) Some important details of method and results are not reported. 
Thus, the validity of this study cannot be evaluated.  
 
1 With and without S9. 
 
GENOTOXICITY (IN VIVO) 
No In vivo mutagenicity/genotoxicity data are available for the candidate substances of the present Flavouring Group Evaluation from chemical group 30. 
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
BW  Body weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese hamster ovary (cells) 
CoA  Co Enzyme A 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EC European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GI   Gastro Intestinal 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
LD50  Lethal Dose, 50%; Median lethal dose 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NAD  Nicotinamide Adenine Dinucleotide  
NADP  Nicotinamide Adenine Dinucleotide Phosphate 
No  Number 
NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
NTP  National Toxicology Program 
SCE  Sister Chromatid Exchange 
SCF  Scientific Committee on Food 
SMART  Somatic Mutation and Recombination Test  
TAMDI Theoretical Added Maximum Daily Intake 
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UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation  
